EVERLAST-A: A Phase 2a Study Design of ORKA-001, a Novel Half-Life Extended IL-23p19 Monoclonal Antibody for Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 6, p. s633, 2025. DOI: 10.25251/jg65bt44. Disponível em: https://skin.dermsquared.com/skin/article/view/3768. Acesso em: 1 may. 2026.